You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunogenicity of the malaria vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malaria Trial (BNT165e, Placebo)

Not yet recruiting
  • Malaria
  • BNT165e
  • Placebo
  • (no location specified)
Sep 29, 2023

Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)

Not yet recruiting
  • Healthy Women of Child Bearing Potential
  • R21/Matrix-M1
  • +2 more
  • (no location specified)
Oct 10, 2023

Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)

Not yet recruiting
  • Malaria
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 28, 2023

Plasmodium Vivax Infection, Malaria Vaccine Trial in Bangkok (Malaria Vaccine, HBV vaccine)

Not yet recruiting
  • Plasmodium Vivax Infection
  • Malaria Vaccine
  • Malaria Vaccine
  • HBV vaccine
  • Bangkok, Thailand
    Faculty of Tropical Medicine
Jan 16, 2023

Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)

Not yet recruiting
  • Malaria
  • +4 more
  • RH5.1 and/or RH5.2-VLP with Matrix-M
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023

Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)

Recruiting
  • Malaria
  • +5 more
  • Matrix M with RH5.1
  • Sheffield, United Kingdom
    Sheffield Teaching Hospitals, Royal Hallamshire Hospital
Nov 14, 2023

Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg

Recruiting
  • Malaria,Falciparum
  • Rabies vaccine
  • +2 more
  • Sigle, Boulkiemdé Province, Burkina Faso
    Institut de Recherche en Sciences de la Santé
Apr 3, 2023

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

Not yet recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Anti-Rabies Vaccine
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023

Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)

Recruiting
  • Malaria
  • Plasmodium Falciparum
  • Pfs48/45 in Matrix-M
  • Oxford, United Kingdom
    CCVTM, University of Oxford
Dec 13, 2022

Malaria Trial in Bagamoyo (SumayaVac-1(SUM-101), Verorab, CHMI)

Not yet recruiting
  • Malaria
  • SumayaVac-1(SUM-101)
  • +2 more
  • Bagamoyo, Tanzania
    Ifakara Health Institute
Dec 1, 2022

Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)

Completed
  • Malaria
  • RTS,S/AS01E (Full dose)
  • +2 more
  • Kumasi, Ghana
  • +1 more
Jan 24, 2023

Malaria Trial in Tempe, Knoxville, San Antonio (BNT165b1, Placebo)

Recruiting
  • Malaria
  • BNT165b1
  • Placebo
  • Tempe, Arizona
  • +2 more
Jan 12, 2023

Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

Not yet recruiting
  • Malaria, Plasmodium Falciparum
  • Matrix-M with RH5.2 VLP and/or R21
  • (no location specified)
Oct 21, 2022

Malaria,Falciparum Trial in Bamako (Pfs230D1-EPA/Matrix-M Vaccine, Verorab Rabies Vaccine)

Active, not recruiting
  • Malaria,Falciparum
  • Pfs230D1-EPA/Matrix-M Vaccine
  • Verorab Rabies Vaccine
  • Bamako, Mali
    Malaria Research Training Center
Sep 7, 2022

GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety

Active, not recruiting
  • Malaria
    • Kumasi, Ghana
    • +1 more
    Jun 23, 2022

    Malaria,Falciparum Trial in Bangkok (R21/Matrix-M vaccination, DHA-PIP, PQ)

    Not yet recruiting
    • Malaria,Falciparum
    • R21/Matrix-M vaccination
    • +2 more
    • Bangkok, Thailand
      Hospital for Tropical Diseases, Faculty of Tropical Medicine, Ma
    Feb 22, 2022

    Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

    Not yet recruiting
    • Covid-19 Pandemics
    • Tuberculosis
    • Pfizer-BioNTech COVID-19 vaccine
    • +2 more
    • Mae Sot, Tak, Thailand
      Shoklo Malaria Research Unit (SMRU)
    Oct 21, 2022

    Malaria,Falciparum Trial in Kilifi (R21 in Matrix- M adjuvant vaccine)

    Completed
    • Malaria,Falciparum
    • R21 in Matrix- M adjuvant vaccine
    • Kilifi, Kenya
      KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
    Aug 19, 2022

    Malaria, Malaria,Falciparum Trial in Bamako (Sanaria® PfSPZ Vaccine, Normal Saline)

    Recruiting
    • Malaria
    • Malaria,Falciparum
    • Sanaria® PfSPZ Vaccine
    • Normal Saline
    • Bamako, Mali
      Malaria Research and Training Center
    Apr 4, 2022

    Malaria, Vivax Trial in Oxford (PvDBPII/Matrix-M1)

    Recruiting
    • Malaria, Vivax
    • PvDBPII/Matrix-M1
    • Oxford, United Kingdom
      CCVTM, University of Oxford, Churchill Hospital
    Feb 8, 2022

    Malaria,Falciparum Trial in Bagamoyo (RH5.1/Matrix-M)

    Enrolling by invitation
    • Malaria,Falciparum
    • RH5.1/Matrix-M
    • Bagamoyo, Tanzania
      Ifakara Health Institute Clinical Trial Facility
    Oct 21, 2022

    Malaria Trial in London, Southampton (RH5.1/ ASO1)

    Completed
    Has Results
    • Malaria
    • RH5.1/ ASO1
    • London, United Kingdom
    • +1 more
    Dec 6, 2021

    Malaria Trial in Bamako (Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine))

    Active, not recruiting
    Has Results
    • Malaria
    • Pfs230D1M-EPA/AS01
    • +4 more
    • Bamako, Mali
      Mrtc/Usttb
    Jul 29, 2022

    Malaria Vaccine Trial in Bangkok (RTS,S/AS01B Fractional dose, Double RTS,S/AS01E Fractional dose, RTS,S/AS01E Standard dose)

    Completed
    Has Results
    • Malaria Vaccine
    • RTS,S/AS01B Fractional dose
    • +6 more
    • Bangkok, Thailand
      Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mah
    Mar 29, 2022

    Malaria, Vivax Trial in Oxford (Pvs25-IMX313/Matrix-M1)

    Recruiting
    • Malaria, Vivax
    • Pvs25-IMX313/Matrix-M1
    • Oxford, United Kingdom
      CCVTM, University of Oxford, Churchill Hospital
    Mar 7, 2022